Acute kidney injury secondary to a combination of renin-angiotensin system inhibitors, diuretics and NSAIDS: “The Triple Whammy”;Fracaso renal agudo secundario a combinación de inhibidores del sistema renina-angiotensina, diuréticos y AINES. “La Triple Whammy”

Nefrologia

Volumn 35, Issue 2, 2015, Pages 197-206

  Garcia Camin, Rosa Maria ^a   Cols, Montse ^b   Chevarria, Julio Leonel ^a   García Osuna, Rosa ^a   Carreras, Marc ^b   Lisbona, Josep Maria ^b   Coderch, Jordi ^b  

^a Hospital de Palamós Palamós Hospital   (Spain)

^b Hospital de Palamos   (Spain)

Author keywords

Acute kidney injury; Anti inflammatory agents; Antihypertensive agents; Diuretics; Drug interactions

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DICLOFENAC; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; IBUPROFEN; INDAPAMIDE; INDOMETACIN; IRBESARTAN; KETOPROFEN; LISINOPRIL; LOSARTAN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OLMESARTAN; PERINDOPRIL; RAMIPRIL; SPIRONOLACTONE; TELMISARTAN; TORASEMIDE; VALSARTAN;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ARTICLE; COMBINATION DRUG THERAPY; COMORBIDITY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GENDER; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY RATE; OBSERVATIONAL STUDY; OUTPATIENT CARE; RETROSPECTIVE STUDY;

EID: 84930251818     PISSN: None     EISSN: 20132514     Source Type: Journal    
DOI: 10.1016/j.nefroe.2015.05.010     Document Type: Article

References (20)

1. Fournier, J.P., Sommet, A., Durrieu, G., Poutrain, J.C., Lapeyre-Mestre, M., Montastruc, J.L., French Network of Regional Pharmacovigilance Centres. Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database Fundam Clin Pharmacol 28 (2014), 230–235.
2. Loboz, K.K., Shenfield, G.M., Drug combinations and impaired renal function – the “Triple Whammy.” Br J Clin Pharmacol., 59, 2005, 239–243.
3. Nitsch, D., Tomlinson LA: Safety of coprescribing NSAIDs with multiple antihypertensive agents. triple drug combinations are associated with increased hospital admission for acute kidney injury, but questions remain. BMJ, 346, 2013, e8713.
4. Adhiyaman, V., Asghar, M., Oke, A., White, A.D., Shah, I.U., Nephrotoxicity in the elderly due to co-prescription of angiotensin converting enzyme inhibitors and nonsteroidal anti-inflammatory drugs. J R Soc Med 94 (2001), 512–514.
5. Liaño, F., Pascual, J., Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group Kidney Int 50 (1996), 811–818.
6. Lou, L.M., Boned, B., Gimeno, J.A., Beguer, P., Cruz, A., Telmo, S., et al. Epidemiología, aspectos clínicos y manejo del fracaso renal agudo en una población envejecida dependiente de un hospital comarcal. Nefrologia 22 (2002), 547–554.
7. Thomas, M.C., Diuretics. ACE inhibitors ans NSAIDs–the triple whammy Med J Austr 172 (2000), 184–185.
8. Chertow, G.M., Burdick, E., Honour, M., Bonventre, J.V., Bates, D.W., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16 (2005), 3365–3370.
9. Hughes, J.S., Averill, R.F., Eisenhandler, J., Goldfield, N.I., Muldoon, J., Neff, J.M., et al. Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management. Med Care 42 (2004), 81–90.
10. Inoriza, J.M., Coderch, J., Carreras, M., Vall-Llosera, L., García-Goñi, M., Lisbona, J.M., et al. La medida de la morbilidad atendida en una organización sanitaria integrada. Gac Sanit 23 (2009), 29–37.
11. Carreras M, Ibern P, Coderch J, Inoriza JM. Análisis de costes por paciente en una organización sanitaria integrada. Fulls econòmics del sistema sanitari 2010; 39:28-37 [Internet; consultado 15 May 2014]. Disponible en: http://www20.gencat. cat/docs/salut/Minisite/catsalut/Coneix_CatSalut/informacio_ economica/fulls_economics/efulls_39.pdf.
12. Carreras, M., Garcia-Goñi, M., Ibern, P., Coderch, J., Vall-Llosera, L., Inoriza, J.M., Estimates of patient cost related with population morbidity: can indirect cost affect the results?. Eur J Health Econ 12 (2011), 289–295.
13. Cots F, Chiarello P, Carreras M, Gonzalez JG, Heras D, de Imaña M, et al. Red Española de Costes Hospitalarios (RECH): bases para una gestión clínica basada en la evidencia. Gest y Eval Cost Sanit 2012; 13:369-83 [Internet; consultado 15 May 2014]. Disponible en: http://www.fundacionsigno.com/archivos/publicaciones/003_SIGNO_13_3.pdf.
14. Red Española de Costes Hospitalarios. Grupo RECH 2010 [Internet; consultado 15 May 2014]. Disponible en: https://www.rechosp.org/rech/cms/en/vision/1/1.
15. Huerta, C., Castellsagué J., Varas-Lorenzo, C., García Rodríguez LA. Non steroideal anti-inflammatory drugs and risk of AFR in the general population Am J Kidney Dis 45 (2005), 531–539.
16. Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013; 346:e8525 [Internet; consultado 15 May 2014). Disponible en: http://dx.doi.org/10.1136/bmj.e8525.
17. Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations and caveats for investigating complications of CKD. Kidney International supplements. 2013; 3:91-111.
18. Gallagher, P., Ryan, C., Byrne, S., Kennedy, J., O'Mahony, D., STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation Int J Clin Pharmacol Ther 46 (2008), 72–83.
19. Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. PLoS ONE. 2012; 7:e34187 [consultado 15 May 2014]. Disponible en: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal. pone.0034187.
20. Fournier, J.P., Sommet, A., Durrieu, G., Poutrain, J.C., Lapeyre-Mestre, M., Montastruc, J.L., French Network of Regional Pharmacovigilance Centres. More on the “Triple Whammy”: antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database. Ren Fail 36 (2014), 1166–1168.